Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
Clinical trial NCT04062019 · UNKNOWN
Trial details
- NCT number
- NCT04062019
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-30
- Primary completion
- 2021-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.